Related Experiment Videos
G-quadruplexes as targets for drug design.
L H Hurley1, R T Wheelhouse, D Sun
1Drug Dynamics Institute, The University of Texas, Austin, TX, USA. dg-dna@mail.utexas.edu
Pharmacology & Therapeutics
|March 31, 2000
Summary
G-quadruplex DNA structures, stabilized by G-tetrads, are crucial in biological processes. This review details compounds that interact with G-quadruplexes, impacting telomerase and DNA dynamics.
Area of Science:
- Molecular Biology
- Biochemistry
- Medicinal Chemistry
Background:
- G-quadruplexes are four-stranded DNA secondary structures stabilized by Hoogsteen base-pairing of guanine tetrads.
- These structures are proposed to form in vivo, particularly in guanine-rich regions like telomeres and promoter regions.
- Direct evidence for in vivo G-quadruplex formation remains limited.
Purpose of the Study:
- To review the design and interaction of three distinct groups of G-quadruplex-interactive compounds.
- To explore the role of G-quadruplex structures in biological functions, such as telomerase inhibition and DNA dynamics.
Main Methods:
- Design and synthesis of anthraquinone, perylene, and porphyrin compounds targeting G-quadruplex DNA.
- Experimental validation of G-quadruplex involvement in telomerase inhibition using anthraquinones.
- Structural and dynamic studies of G-quadruplex-ligand complexes with perylenes and porphyrins.
Main Results:
- Anthraquinone compounds provided proof-of-concept that G-quadruplex structures are required for telomerase inhibition.
- Perylene compounds elucidated the structure of G-quadruplex-ligand complexes and their impact on quadruplex formation and unwinding dynamics.
- Porphyrin compounds demonstrated a link between biological effects and G-quadruplex interactions.
Conclusions:
- G-quadruplex structures are valid targets for therapeutic intervention, particularly in cancer via telomerase inhibition.
- The studied compounds offer diverse mechanisms for interacting with and modulating G-quadruplex DNA.
- Further research into G-quadruplex-ligand interactions can lead to novel therapeutic strategies.